Search

You searched for "therapeutics"

378 results found

A life outside ophthalmology

3 April 2023 | | EYE - General
Lloyd Paul Aiello. It was an absolute privilege to speak to Lloyd Paul Aiello, Professor of Ophthalmology, Harvard Medical School, and Vice President of Ophthalmology and Director, Beetham Eye Institute, Joslin Diabetes Center, USA. Prof Aiello is a third-generation ophthalmologist,...

MOSUK Annual Meeting 2026

25 February 2026
Medical Ophthalmological Society's 27th Annual Meeting

NYU Langone Health performs world’s first whole-eye & partial-face transplant

15 November 2023 | NYU Langone, eye transplant, Face transplant, surgery, therapies, Aaron James, USA, Eduardo D. Rodriguez
Landmark whole-eye transplant is a major paradigm shift for potential vision therapies.

Addressing medical risk factors for diabetes and understanding the new systemic treatments

1 February 2014 |
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...

Mucormycosis: In conversation with Dr Deepak Haldipur and Dr Aditya Moorthy

15 July 2021 | | EYE - Orbit, EYE - Oculoplastic, EYE - General
COVID-19 has ravaged the world in the past 18 months. The second wave in many countries was deadlier than the first. Mucormycosis, infamously labelled ‘the black fungus’ has affected some countries, such as India, in epidemic proportions within this COVID...

An interview with a glaucoma consultant: Insights for aspiring trainees

2 October 2025 | | EYE - Glaucoma
In this article, Resident Doctor Chi Kit Yan sits down with Consultant Glaucoma Specialist Salman Sadiq and explores the daily life of a glaucoma specialist, the pros and cons of the role, how trainees can prepare for this subspecialty, and...

People watching…

5 June 2023 |
Confession time: I love a good airport lounge! Not only does it mean that you are about to go get some sunshine on a well-deserved break, it also provides a perfect opportunity to watch people go by. And what a...

A life less miserable

2 December 2024
Secret reveal… I love musicals! Ignoring regular derision from high-brow critics, musical theatre continues to maintain a strong presence in the hearts and minds of the people. Broadway and the West End thrive with new shows and classic productions entertaining...

Patients blinded by stem cells! How safe are they really?

1 October 2018 | | EYE - Vitreo-Retinal, EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Patients blinded by stem cells! How safe are they really? Ever since the successful results following...

Severe conjunctival cicatrisation secondary to chronic glaucoma therapy

1 August 2015 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
The timing of glaucoma filteration surgery during the course of chronic progressive glaucoma remains a contentious issue amongst glaucoma specialists. The vast majority support the use of maximal medical treatment initially to achieve the target pressure. Surgical procedures are only...

Fusarium keratitis in a patient with alcohol dependence

1 April 2014 | | EYE - Cornea, EYE - Imaging, EYE - General
Treatment of fungal keratitis secondary to the Fusarium species remains a challenge. Although relatively more common in warmer climates, this corneal infection is rare in the UK. Most cases have been reported in farmers and are often preceded by trauma....

Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?

1 February 2017 | | EYE - Vitreo-Retinal
There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...